Back to search
FDAFDA · Food and drugs·Recall number D-0194-2025

Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8024-01 .

Published January 22, 2025 · Recall initiated: December 12, 2024

Summary

FDA records drug Class III recall D-0194-2025, published January 22, 2025 and initiated December 12, 2024. Recalling firm: Akron Pharma, Inc.; Status: Ongoing; Reported quantity: 6429 bottles; Lot: Lot #: KDT0124001, Exp 08/31/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akron Pharma, Inc.
Distributor
Nationwide in the US
Lot
Lot #: KDT0124001, Exp 08/31/2026
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Acetaminophen Regular Strength, 325 mg, 100 Tablets per bottle, Akron Pharma, Inc., 373 RT US 46 W Building E, Suite 117, Fairfield, NJ 07004, NDC 71399-8024-01 . recalled?

Yes. FDA published recall D-0194-2025 on January 22, 2025. Reported hazard: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.

What should I do if I have this product?

Voluntary: Firm initiated · Letter